Embryonic Stem-Cell Research Opponents Appeal Funding Ruling

Opponents of human embryonic stem-cell research asked a federal appeals court to reverse a judge’s ruling that the U.S. may continue to fund experiments in the field.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.